Singleto2 Therapeutics LLC
Summit, NJ
- UEI
- H17BGQ86LAR4
- CAGE
- 7FMM6
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 22 Oakland Pl, Summit, NJ 07901, USA
- Website
- singleto2.com
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A compliant superhydrophobic antimicrobial photodynamic therapy bandage for the prevention of multidrug resistant… | National Institute of Allergy and Infectious Diseases | $300,000 | |
| Sttr phase i: safe disinfection and oxygen-level enrichment in recirculating aquaculture systems (RAS) using singlet… | Division of Industrial Innovation | $255,999 | |
| 3D-printed superhydrophobic-tipped optical fiber for targeted periodontal photodynamic therapy | National Institute of Dental and Craniofacial Research | $1,516,255 | |
| Superhydrophobic implantable surface and 3D printing technology for targeted dental photodynamic therapy | National Institute of Dental and Craniofacial Research | $224,714 |
Quick answers
What is Singleto2 Therapeutics LLC's UEI?
Singleto2 Therapeutics LLC's Unique Entity ID (UEI) in SAM.gov is H17BGQ86LAR4.
What is Singleto2 Therapeutics LLC's CAGE code?
Singleto2 Therapeutics LLC's CAGE code is 7FMM6.
Where is Singleto2 Therapeutics LLC located?
Singleto2 Therapeutics LLC's physical address in SAM.gov is 22 Oakland Pl, Summit, NJ 07901, USA.
Is Singleto2 Therapeutics LLC registered in SAM.gov?
Yes. Singleto2 Therapeutics LLC's SAM.gov registration is active through July 30, 2027.
What is Singleto2 Therapeutics LLC's most recent federal award?
Singleto2 Therapeutics LLC's most recent federal grant award is A compliant superhydrophobic antimicrobial photodynamic therapy bandage for the prevention of multidrug resistant… (R41AI183969), from National Institute of Allergy and Infectious Diseases, on April 12, 2024.
On GovTribe
See Singleto2 Therapeutics LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors